169 related articles for article (PubMed ID: 38002025)
81. Factors Predicting Pelvic Lymph Node Metastasis, Relapse, and Disease Outcome in Pattern C Endocervical Adenocarcinomas.
Alvarado-Cabrero I; Roma AA; Park KJ; Rutgers JKL; Silva EG
Int J Gynecol Pathol; 2017 Sep; 36(5):476-485. PubMed ID: 28134668
[TBL] [Abstract][Full Text] [Related]
82. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution.
Koh HH; Park E; Kim HS
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626765
[TBL] [Abstract][Full Text] [Related]
83. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract][Full Text] [Related]
84. Endometrial endometrioid carcinoma with microcystic, elongated, and fragmented (MELF) pattern invasion.
Heffernan S; Ó Riain C
Int J Gynecol Cancer; 2021 Sep; 31(9):1307-1308. PubMed ID: 34489359
[No Abstract] [Full Text] [Related]
85. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
86. Endometrial Endometrioid Carcinoma With Large Cystic Growth Configuration and Deceptive Pattern of Invasion Associated With Abundant Nodular Fasciitis-like Stroma: A Unique Hitherto Unreported Histology in Endometrioid Carcinoma.
Švajdler M; Michal M; Dubinský P; Švajdler P; Ondič O; Michal M
Adv Anat Pathol; 2016 Nov; 23(6):381-384. PubMed ID: 27740962
[TBL] [Abstract][Full Text] [Related]
87. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
[TBL] [Abstract][Full Text] [Related]
88. Papillary Endometrioid Carcinoma of Intermediate Grade with Infiltration in a Leiomyoma.
Shopov S
Folia Med (Plovdiv); 2020 Mar; 62(1):190-194. PubMed ID: 32337888
[TBL] [Abstract][Full Text] [Related]
89. [Correlation of micropapillary patten, cribriform pattern and retraction clefting of endocervical adenocarcinoma with the Silva classification system and prognosis].
Li YM; He YY; Sun PL; Gao HW
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):596-601. PubMed ID: 35750638
[No Abstract] [Full Text] [Related]
90. Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
Chung T; DO SI; Na K; Kim G; Jeong YI; Kim YW; Kim HS
Anticancer Res; 2018 Jun; 38(6):3551-3558. PubMed ID: 29848709
[TBL] [Abstract][Full Text] [Related]
91. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
92. A novel Silva pattern-based model for precisely predicting recurrence in intermediate-risk cervical adenocarcinoma patients.
Guo C; Tao X; Zhang L; Zhang Y; Hua K; Qiu J
BMC Womens Health; 2022 Sep; 22(1):377. PubMed ID: 36114524
[TBL] [Abstract][Full Text] [Related]
93. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
94. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
[No Abstract] [Full Text] [Related]
95. Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.
Koh HH; Park E; Kim HS
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204416
[TBL] [Abstract][Full Text] [Related]
96. Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups.
Rau TT; Bettschen E; Büchi C; Christe L; Rohner A; Müller MD; Carlson JW; Imboden S; Zlobec I
Mod Pathol; 2021 Jan; 34(1):222-232. PubMed ID: 32728223
[TBL] [Abstract][Full Text] [Related]
97. Prognostic value of pathological characteristics of invasive margins in early-stage squamous cell carcinomas of the uterine cervix.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Lekawanvijit S; Siriaunkgul S
Asian Pac J Cancer Prev; 2013; 14(9):5165-9. PubMed ID: 24175794
[TBL] [Abstract][Full Text] [Related]
98. Endocervical Adenocarcinoma Showing Microcystic, Elongated, and Fragmented (MELF) Pattern of Stromal Invasion: A Single-Institutional Analysis of 10 Cases with Comprehensive Clinicopathological Analyses and Ki-67 Immunostaining.
Bae H; Kim HS
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002025
[TBL] [Abstract][Full Text] [Related]
99. Usual-Type Endocervical Adenocarcinoma with a Microcystic, Elongated, and Fragmented Pattern of Stromal Invasion: A Case Report with Emphasis on Ki-67 Immunostaining and Targeted Sequencing Results.
Choi S; Hwang S; Do SI; Kim HS
Case Rep Oncol; 2020; 13(3):1421-1429. PubMed ID: 33442366
[TBL] [Abstract][Full Text] [Related]
100. [Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis].
Zhang XB; Zhao CL; Qi XL; Qin Y; Wang Y; Shen DH
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):811-815. PubMed ID: 30585018
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
